The Role of CTCs in Primary and Metastatic Breast CancerWednesday, 4 September 2013 at 10:35 Add to Calendar ▼2013-09-04 10:35:002013-09-04 11:35:00Europe/LondonThe Role of CTCs in Primary and Metastatic Breast CancerMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com The detection of circulating tumor cells in the blood (CTCs) is a common phenomenon seen in 10-20% of primary breast cancer patients. Recent studies have shown a prognostic potential of CTC in both primary and metastatic setting. The evaluation of CTC may become one of the crucial markers for prediction of survival and therapy monitoring. |